Why Exact Sciences Shares Rallied 16.7% in October

After reporting third-quarter financial results that were better than expected, Exact Sciences (NASDAQ: EXAS) shares gained 16.7% in October, according to S&P Global Market Intelligence.

Exact Sciences' quarterly results show that more doctors and patients are choosing its Cologuard test for colon cancer screening.

IMAGE SOURCE: GETTY IMAGES.